# DESCRIPTION

## STATEMENT OF RIGHTS TO INVENTIONS MADE UNDER FEDERALLY SPONSORED RESEARCH

- not applicable

## TECHNICAL FIELD

- polypeptide and genome engineering

## BACKGROUND

- introduce artificial nucleases
- describe applications of nucleases
- explain intermolecular ion pairs
- discuss zinc finger proteins
- describe non-specific phosphate contacting side chains
- discuss optimal cleavage specificity
- motivate need for additional methods

## SUMMARY

- introduce nuclease specificity methods
- describe artificial nucleases with mutations
- outline methods for increasing cleavage specificity
- summarize targeted chromatin cleavage and integration
- introduce engineered nuclease cleavage half domains
- describe mutations in FokI or FokI homologues
- outline mutations in dimerization domain
- summarize preferred embodiments of mutations
- describe fusion proteins with engineered cleavage half domains
- outline incorporation into artificial nucleases
- describe mutations in DNA binding domain
- summarize polynucleotides encoding engineered cleavage half domains
- describe cells comprising nucleases and polynucleotides
- outline specific embodiments of fusion polypeptides
- introduce modified cells and methods
- describe targeted cleavage of cellular chromatin
- motivate engineered cleavage half-domains
- describe methods for increasing engineered nuclease specificity
- describe methods to decrease off-target nuclease activity
- outline method for cleaving cellular chromatin in a region of interest
- describe methods of altering a region of cellular chromatin
- describe donor polynucleotides for altering cellular chromatin
- describe cells comprising polypeptides and/or polynucleotides
- describe kit comprising fusion protein or polynucleotide
- summarize applications of the invention
- conclude the invention

## DETAILED DESCRIPTION

- establish general context

### Definitions

- define nucleic acid terms
- define polypeptide terms
- define binding terms
- define DNA binding molecule
- define DNA binding protein
- define zinc finger DNA binding protein
- define TALE DNA binding domain
- define engineered zinc finger proteins
- define selected zinc finger proteins
- define TtAgo system
- define recombination
- define homologous recombination
- define cleavage
- define cleavage half-domain
- define engineered cleavage half-domain
- define sequence
- define episome
- define endogenous molecule
- define product of exogenous nucleic acid
- define fusion molecule
- define gene
- define gene expression
- define modulation of gene expression
- define region of interest
- define safe harbor locus
- define reporter gene
- define eukaryotic cells
- define operative linkage
- define functional fragment
- define polynucleotide vector
- define subject and patient
- define treating and treatment
- define zinc finger proteins
- describe DNA-binding domain
- motivate use of nuclease
- introduce TAL effector
- describe TALEN
- introduce mega TAL
- introduce compact TALEN
- describe CRISPR/Cas nuclease system
- introduce TtAgo system
- describe Ago-guide DNA complex
- summarize fusion molecules
- define fusion molecules
- list DNA-binding domains
- list functional domains
- describe construction of fusion molecules
- discuss accessible regions of chromatin
- formulate fusion molecules with carriers
- select functional components
- describe nuclease technology
- discuss ZFNs and TALENs
- define nucleases
- describe TALENs
- describe mega TAL nucleases
- describe compact TALENs
- describe meganucleases
- describe DNA-binding domains from meganucleases
- describe engineering meganucleases
- describe zinc finger nucleases
- describe engineering zinc finger binding domains
- describe linkers between zinc fingers
- describe cleavage domains from endonucleases
- define Type IIS restriction enzymes
- describe cleavage domain
- motivate FokI cleavage domain
- describe mutations in FokI cleavage domain
- describe engineered cleavage half-domains
- describe obligate heterodimers
- describe fusion proteins
- describe mutations in FokI catalytic domain
- describe nuclease domains
- describe split-enzyme technology
- describe screening for nuclease activity
- introduce CRISPR/Cas system
- describe CRISPR-Cpf1 system
- describe functional derivatives of Cas protein
- describe catalytically inactive cleavage domains
- describe nickases

### Delivery

- introduce delivery methods
- list suitable cells for delivery
- describe viral and non-viral gene transfer methods
- summarize U.S. patents related to delivery methods
- describe non-viral delivery methods
- introduce electroporation and lipofection
- describe biolistics and virosomes
- introduce sonoporation and mRNA delivery
- describe commercial nucleic acid delivery systems
- introduce viral vector delivery systems
- describe retroviral, lentiviral, adenoviral, and adeno-associated viral vectors
- summarize characteristics of viral vectors
- describe recombinant AAV vectors
- introduce adenoviral vectors
- describe replication-deficient recombinant adenoviral vectors
- summarize packaging cells and viral vector production
- describe targeted delivery methods
- introduce stem cell delivery
- isolate and modify stem cells
- administer vectors for transduction
- describe administration methods
- discuss pharmaceutical carriers
- list suitable cell lines
- motivate engineered nucleases
- list genetic diseases
- describe treatment of infections
- target viral genomes and receptors
- discuss gene modification methods
- apply compositions to stem cell therapies
- apply compositions to somatic cell therapy
- discuss non-therapeutic applications

### EXAMPLES

- design ZFNs targeted to BCL11A and TCRA genes
- introduce FokI mutants targeting interaction with phosphates
- test FokI mutants for cleavage activity against BCL11A target
- analyze off-target sites using unbiased capture analysis
- test FokI mutants in TCRA-specific ZFNs
- analyze off-target sites in TCRA-specific ZFNs
- design novel engineered zinc finger backbone mutations
- analyze zinc finger sequences for positively charged amino acids
- identify potential substitutions in zinc finger backbone
- test zinc finger backbone mutations in TCRA-specific ZFNs
- analyze off-target activity in TCRA-specific ZFNs
- test zinc finger backbone mutations in BCL11A-specific ZFNs
- analyze off-target activity in BCL11A-specific ZFNs
- titrate ZFN partners for optimal on-target activity
- analyze effect of titration on off-target cleavage
- perform Western analysis to detect ZFN protein expression
- analyze effect of titrating both ZFN partners on off-target cleavage
- combine ZFN partner titrations with FokI-phosphate contact mutations
- analyze on-target and off-target activity in combined approach
- examine effect on all off-target sites using combined approach
- present experimental results
- describe example 6
- describe example 7
- describe example 8
- describe example 9
- present additional specificity studies
- conclude and provide general statements

